Autistic Eye Contact?

April 3, 2025 updated by: Jos Boer, UMC Utrecht

Autistic Eye Contact? A Hermeneutic Phenomenological Multicenter Study on Experiences With Eye Contact Between Adults With and Without Autism Spectrum Disorder With Use of Semi-structured Interviews. Using Semi-structured Interviews, the Experiences of People With and Without Autism Regarding Eye Contact Were Made Clear. The Topic List for These Semi-structured Interviews Was Developed in Co-design With People With Autism.

This research explored both breadth and depth of the experiences with eye contact in adults with and without ASD. A hermeneutic phenomenological multicenter design was used in which 15 adults with ASD and 15 adults without ASD were interviewed, using semi-structured interviews. Analyses using Multisite Qualitative Analysis (MSQA) and PRICE-model for saturation.

Study Overview

Status

Completed

Detailed Description

This study aimed to examine the subjective eye contact experiences of adults with ASD compared to adults without ASD. Factors such as beliefs about the phenomenon, problems because of eye contact, development in eye contact, interpretations of others and more were explored.

To get insight in the subjective eye contact experiences of adults with ASD compared to adults without ASD, a hermeneutic phenomenological design using Multisite Qualitative Analysis (MSQA) and the PRICE-model for saturation during data analysis were used. MSQA enables the highest qualitative accuracy, the gathering of rich context-specific insights and maximizing the applicability. Semi-structured interviews was chosen for data collection and analysis because adults with ASD attach importance to on the one hand having the space to share their experiences in their own way, but on the other hand need frameworks to know what is asked of them. Hermeneutic phenomenological approach, grounded in philosophical concepts developed by Heidegger and Gadamer, made it possible to create meaning on how people experience a situation or phenomenon, such as eye contact, in a flexible and practical way.

Multisite design was chosen in response to criticism that single-site findings would limit the relevance and transferability and reliability to other settings. The Consolidated criteria for reporting qualitative studies (COREQ) checklist was used for reporting the research data. For the checklist. In addition, the Standards for Reporting Qualitative Research (SRQR) checklist was used. The research design was developed in collaboration with three adults with ASD and three adults without ASD, in order to include relevant information from the perspective of the target groups.

The semi-structured interviews were conducted using a topic list. This topic list consisted of the following sub questions:

Meaning:

  • What do you think is the meaning of the term eye contact?
  • In your opinion, are there different ways of making eye contact? If so, which?
  • What do you think about the opinion that eye contact is abnormal in autism?

Development:

  • Was the subject of eye contact brought up in your youth? If so, how?
  • Did you learn how to make eye contact?
  • Does your experiences with eye contact influenced how you lived your life? How?

Initiative to eye contact:

  • Does it matter to you how others make eye contact with you? Why?
  • Does the way you make eye contact with others depend on the situation or the person? Why?
  • Do you adjust your eye contact to situations and/or people?

Interpretation of eye contact:

  • Are there for you different ways of having eye contact? Which one?
  • Are there for you different meanings of eye contact? Which one?

Dealing with eye contact:

  • How do you make eye contact when interacting with others? Does that happen automatically?
  • Do you consciously think about having eye contact? How come?
  • How do you experience having eye contact with others? How come?

Wishes:

Would you like your eye contact with others to be different?/Do you need to improve the eye contact you have with others? If not, why? If so, why?

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Overijssel
      • Deventer, Overijssel, Netherlands, 7416 SB
        • Dimence Groep

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The Netherlands

Description

Adults with autism

Inclusion criteria

  • Diagnosed with autism according to an internationally recognized classification system
  • Receiving outpatient treatment at a specialized autism center in the Netherlands
  • Being able to understand the themes to be discussed
  • Motivation to participate in the research

Exclusion criteria

  • Insufficient command of the Dutch language
  • Use of alcohol and/or recreational drugs during the study
  • Too much mental instability to participate in the study
  • Familiarity with treatment in intellectual disability care

Adults without autism

Inclusion criteria

  • Being able to understand the themes to be discussed
  • Motivation to participate in the research

Exclusion criteria

  • Insufficient command of the Dutch language
  • Use of alcohol and/or recreational drugs during the study
  • Too much mental instability to participate in the study
  • Familiarity with treatment in intellectual disability care

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Autism
The group of adults with ASD consisted of participants who were receiving outpatient treatment at one of three specialized centers for ASD, located in Deventer, Rotterdam or Amsterdam in the Netherlands.
Neurotypicals
The group of adults without ASD consisted of participants who were never diagnosed with autism and lived in the Netherlands.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experiences with eye contact with use of semi-structured interviews
Time Frame: June to September 2024
The subjective eye contact experiences of adults with ASD compared to adults without ASD, using semi-structured interviews
June to September 2024

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Study Chair: Nynke Boonstra, Professor, UMC Utrecht

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 3, 2024

Primary Completion (Actual)

September 30, 2024

Study Completion (Actual)

September 30, 2024

Study Registration Dates

First Submitted

March 28, 2025

First Submitted That Met QC Criteria

April 3, 2025

First Posted (Actual)

April 10, 2025

Study Record Updates

Last Update Posted (Actual)

April 10, 2025

Last Update Submitted That Met QC Criteria

April 3, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

On request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder (ASD)

Subscribe